Management of Abdominal Aortic Aneurysms in 2021

Abdominal aortic aneurysms (AAA) are those of >3 cm aortic diameter.  They run the risk of rupture and ensuing death by bleeding. In consequence, they are treated to repair the aneurysm before it ruptures. 

Manejo de los aneurismas de aorta abdominal en 2021

In this regard, the most relevant predictor of rupture is aneurysm diameter. That is, the greater the aneurysm, the greater the risk. 

Randomized studies have not shown advantages in survival when <5.5 cm aneurysms were surgically treated vs. close observation. This evidence supports the use of 5.5 cm diameter as a cutoff value. Therefore, watching <5.5 cm aneurysms closely is safe and cost effective. 

Close observation, among other things, will detect aneurysms that might present accelerated sac growth (>1 cm in one year), even though we lack rigorous information to support intervention in this context. 

The key clinical points for AAA management in 2021 are:

  • Risk factors include advanced age, male sex, family history, smoking, hypercholesterolemia, and hypertension. Diabetics run the lowest risk. 
  • In men, AAA should be repaired when they are ≥5.5 cm diameter, and in women, when they are ≥5 cm.
  • Endovascular repair of AAA is associated with lower risk of perioperative complications and death vs. open surgery. 
  • The initial advantage of endovascular repair is kept for 2 or 3 years after procedure. There are no differences at long term in terms of death. 
  • Endovascular repair is associated to more reinterventions, in general simple procedures. Throughout patient life, open surgery is associated to more reinterventions due to laparotomy. 
  • For close observation, both CT and echocardiography are adequate.

Read also: TCT 2021 | STOPDAPT-2 and MASTER-DAPT: The Conversation Continues from ESC to TCT.


This is the most succinct information, and it is not much different from what have known for some time. Data are reassuring, seeing as they indicate we understand this disease, and thus we can take preventive action. 

nejmcp2108504

Original Title: Management of Abdominal Aortic Aneurysms.

Reference: Andres Schanzer et al. N Engl J Med 2021;385:1690-8. DOI: 10.1056/NEJMcp2108504.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...